Franklin Resources’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.3M Sell
475,156
-125,290
-21% -$4.56M ﹤0.01% 967
2025
Q1
$21.7M Buy
600,446
+173,087
+41% +$6.27M 0.01% 877
2024
Q4
$18M Buy
427,359
+208,456
+95% +$8.77M 0.01% 938
2024
Q3
$12.3M Sell
218,903
-74,991
-26% -$4.21M ﹤0.01% 1046
2024
Q2
$12.1M Buy
293,894
+77,978
+36% +$3.2M ﹤0.01% 1011
2024
Q1
$10.1M Buy
215,916
+1,178
+0.5% +$55K ﹤0.01% 1071
2023
Q4
$10.3M Buy
214,738
+25,144
+13% +$1.2M ﹤0.01% 924
2023
Q3
$6.76M Buy
189,594
+9,976
+6% +$356K ﹤0.01% 1001
2023
Q2
$8.29M Buy
179,618
+126
+0.1% +$5.81K ﹤0.01% 969
2023
Q1
$7.2M Sell
179,492
-1,600
-0.9% -$64.2K ﹤0.01% 1003
2022
Q4
$8.39M Buy
181,092
+2,729
+2% +$126K ﹤0.01% 979
2022
Q3
$7.39M Sell
178,363
-834
-0.5% -$34.5K ﹤0.01% 1009
2022
Q2
$10.7M Hold
179,197
0.01% 939
2022
Q1
$13M Sell
179,197
-14
-0% -$1.02K 0.01% 952
2021
Q4
$15.1M Sell
179,211
-23,250
-11% -$1.96M 0.01% 962
2021
Q3
$18.3M Buy
202,461
+76
+0% +$6.85K 0.01% 911
2021
Q2
$19.3M Sell
202,385
-42
-0% -$4.01K 0.01% 866
2021
Q1
$23M Sell
202,427
-51,651
-20% -$5.88M 0.01% 805
2020
Q4
$35.2M Sell
254,078
-128,749
-34% -$17.8M 0.01% 682
2020
Q3
$31.5M Buy
382,827
+354
+0.1% +$29.1K 0.02% 663
2020
Q2
$31.7M Hold
382,473
0.02% 630
2020
Q1
$17M Buy
382,473
+11,823
+3% +$525K 0.01% 705
2019
Q4
$15.8M Buy
370,650
+225,200
+155% +$9.62M 0.01% 810
2019
Q3
$6.22M Buy
+145,450
New +$6.22M ﹤0.01% 964
2015
Q3
Sell
-214,300
Closed -$21.9M 1619
2015
Q2
$21.9M Hold
214,300
0.01% 866
2015
Q1
$13.3M Hold
214,300
0.01% 979
2014
Q4
$9.4M Sell
214,300
-6,500
-3% -$285K ﹤0.01% 1058
2014
Q3
$12.5M Sell
220,800
-22,300
-9% -$1.26M 0.01% 1005
2014
Q2
$10.9M Hold
243,100
﹤0.01% 1041
2014
Q1
$11.9M Buy
+243,100
New +$11.9M 0.01% 993